Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127760271 | 12776027 | 1 | I | 20160913 | 20160923 | 20160923 | PER | US-TEVA-693267USA | TEVA | 0.00 | M | Y | 122.58000 | KG | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127760271 | 12776027 | 1 | PS | PROVIGIL | MODAFINIL | 1 | Unknown | AB8024A | 20717 | 200 | MG | ||||||||
| 127760271 | 12776027 | 2 | C | AFRIN | OXYMETAZOLINE | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 3 | C | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 4 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 6 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 7 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 8 | C | DILTIAZEM. | DILTIAZEM | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 9 | C | FENOFIBRATE. | FENOFIBRATE | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 11 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 12 | C | MELOXICAM. | MELOXICAM | 1 | 0 | ||||||||||||
| 127760271 | 12776027 | 13 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127760271 | 12776027 | 1 | Narcolepsy |
| 127760271 | 12776027 | 2 | Respiratory tract congestion |
| 127760271 | 12776027 | 3 | Emphysema |
| 127760271 | 12776027 | 5 | Blood cholesterol abnormal |
| 127760271 | 12776027 | 6 | Supplementation therapy |
| 127760271 | 12776027 | 7 | Nervousness |
| 127760271 | 12776027 | 8 | Cardiac disorder |
| 127760271 | 12776027 | 10 | Thyroid disorder |
| 127760271 | 12776027 | 11 | Hypertension |
| 127760271 | 12776027 | 12 | Arthritis |
| 127760271 | 12776027 | 13 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127760271 | 12776027 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127760271 | 12776027 | Drug dose omission | |
| 127760271 | 12776027 | Somnolence | |
| 127760271 | 12776027 | Sudden onset of sleep |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127760271 | 12776027 | 1 | 2014 | 0 |